We are live on ! Find out more
MCM

M28 Capital Management Portfolio holdings

AUM $47.2M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
-5.79%
1 Year Est. Return
+32.31%
3 Year Est. Return
+200.03%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$58.6M
AUM Growth
-$14.4M
Cap. Flow
-$6.63M
Cap. Flow %
-11.3%
Top 10 Hldgs %
100%
Holding
11
New
–
Increased
–
Reduced
–
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
BBIO icon
BridgeBio Pharma
BBIO
+$4.19M
2
SWTX
SpringWorks Therapeutics
SWTX
+$2.44M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WVE icon
1
Wave Life Sciences
WVE
$902M
$36.8M 62.8%
5,664,548
– –
IVVD icon
2
Invivyd
IVVD
$263M
$6.61M 11.28%
9,248,250
– –
TGTX icon
3
TG Therapeutics
TGTX
$8.27B
$5.82M 9.92%
161,600
– –
GUTS icon
4
Fractyl Health
GUTS
$97.4M
$3.01M 5.13%
1,856,117
– –
PRQR icon
5
ProQR Therapeutics
PRQR
$262M
$2.08M 3.55%
1,019,498
– –
CRIS icon
6
Curis
CRIS
$2.72M
$1.21M 2.06%
26,053
– –
SLN
7
Silence Therapeutics
SLN
$812M
$1.07M 1.83%
185,100
– –
ARWR icon
8
Arrowhead Research
ARWR
$11.4B
$1.06M 1.82%
67,400
– –
RCKT icon
9
Rocket Pharmaceuticals
RCKT
$377M
$945K 1.61%
385,680
– –
BBIO icon
10
BridgeBio Pharma
BBIO
$14.1B
– –
-121,200
Closed -$4.19M
SWTX
11
DELISTED
SpringWorks Therapeutics
SWTX
– –
-55,200
Closed -$2.44M

Similar funds

OGC
One68 Global Capital New York $47.2M AUM 6.52% 1-Year Est. Return
BJB
Broadhurst Jeffrey B $47M AUM
JCM
JAT Capital Management Greenwich, Connecticut $47.4M AUM 177.04% 1-Year Est. Return
FDG
Financial Discovery Group Atlanta, Georgia $46.9M AUM
BAM
BTS Asset Management Lincoln, Massachusetts $47.4M AUM 1.28% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
NPCM
New Paradigm Capital Management Great Falls, Virginia $46.8M AUM
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return

M28 Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, M28 Capital Management held 11 positions worth $58.6M, down 20% from $73M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

M28 Capital Management withdrew a net $6.63M in Q2 2025, closing 2 positions. Its most notable exit was BridgeBio Pharma, an estimated $4.19M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • M28 Capital Management fully exited BridgeBio Pharma in Q2 2025, selling an estimated $4.19M.
  • M28 Capital Management's ten largest holdings make up 100% of its $58.6M portfolio in Q2 2025.
  • M28 Capital Management opened 0 new positions and closed 2 in Q2 2025.
  • M28 Capital Management's portfolio value fell 20% quarter-over-quarter to $58.6M.

Based on M28 Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.